Skip to main content
. 2021 Mar 10;95(7):e01968-20. doi: 10.1128/JVI.01968-20

TABLE 4.

Antibody responses in experimentally compared to naturally reptarenavirus-infected boasa

Animal Virus(es) used for inoculation or immunization ELISA titer (UGV-1 lysate)
Blood smear score Neut. titer
RT-PCR result(s)
IgY IgM UGV-1 UHV-1 ABV-1 TSMV-2 S5-like
3.1 0-bleed 0.151 0.052 0 0 0 0 ND ND Neg
3.1. final 0.201 0.058 0 0 0 0 ND ND Neg
3.2 0-bleed 0.199 0.067 0 0 0 0 ND ND Neg
3.2 final 0.109 0.026 0 0 0 0 ND ND Neg
3.3 postimm. Immunized with recombinant UHV-1 NP 3.227 0.069 0 ND ND ND ND ND Neg
3.3 final UHV-1, ABV-1, later UGV-1 3.311 0.109 0 250 150 75 ND ND UGV-1
3.4 postimm. Immunized with inactivated UHV (UHV-1 and ABV-1) 2.838 0.059 0 ND ND ND ND ND Neg
3.4 final UHV-1, ABV-1, later UGV-1 3.092 0.109 0 150 100 75 ND ND UGV-1
3.5 postimm. Immunized with inactivated UHV (UHV-1 and ABV-1) 1.303 0.080 0 ND ND ND ND ND Neg
3.5 final UHV-1 and ABV-1 1.901 0.045 0 500 500 200 ND ND UHV-1, ABV-1
3.6 postimm. Immunized with inactivated UHV (UHV-1 and ABV-1) 3.212 0.026 0 ND ND ND ND ND Neg
3.6 final UHV-1 and ABV-1 3.103 0.041 0 200 400 50 ND ND Neg
3.7 final UHV-1 and ABV-1 3.018 0.081 0 200 150 400 ND ND ABV-1
3.8 final UHV-1 and ABV-1 3.177 0.066 0 400 0 800 ND ND ABV-1
3.9 final UHV-1 and ABV-1 3.177 0.042 0 400 200 800 ND ND ABV-1
3.10 final UHV-1 and ABV-1 2.910 0.039 0 400 200 50 ND ND ABV-1
3.11 final UHV-1, ABV-1, and UGV-1 3.267 0.059 0 400 50 0 ND ND UGV-1
3.12 final UHV-1, ABV-1, and UGV-1 3.319 0.060 0 400 400 400 ND ND UGV-1
3.13 final UGV-1 3.372 0.262 0 400 50 400 ND ND UGV-1
3.14 final UGV-1 3.370 0.049 0 400 1,600 200 ND ND UGV-1
Nat. inf. 1 3.042 0.061 0 200 0 6,400 UGV, TSMV-2
Nat. inf. 2 1.839 0.085 0 1,000 50 3,200 TSMV-2
Nat. inf. 3 1.186 0.047 0 500 400 3,400 S5, TSMV-2
Nat. inf. 4 0.045 0.008 0 700 6,400 6,400 Neg
Nat. inf. 5 0.150 0.089 2 90 100 800 UGV, S5, TSMV-2
Nat. inf. 6 0.621 0.045 0 800 350 1,600 S5
Nat. inf. 7 0.222 0.116 2 450 50 350 UGV, S5
Nat. inf. 8 1.914 0.026 0 750 400 3,500 Neg
Nat. inf. 9 0.161 0.021 1 400 300 1,600 UGV, S5
Nat. inf. 10 2.348 0.122 0 400 0 2,200 S5
Nat. inf. 11 2.270 0.257 0 600 800 750 Neg
Nat. inf. 12 0.054 0.018 3 800 1,700 2,400 UGV, S5
Nat. inf. 13 1.546 0.101 0 200 0 300 UGV, TSMV-2
Nat. inf. 14 0.085 0.012 2 1,700 50 1,200 UGV, S5, TSMV-2
Nat. inf. 15 1.828 0.262 1 1,700 300 1,200 UGV
Nat. inf. 16 1.588 0.132 0 800 75 3,700 UGV, S5, TSMV-2
Nat. inf. 17 1.049 0.416 3 1,600 0 6,400 UGV, S5, TSMV-2
Nat. inf. 18 0.699 0.015 1 300 250 6,000 UGV, S5, TSMV-2
Nat. inf. 19 0.217 0.017 0 250 250 2,800 S5, TSMV-2
Nat. inf. 20 0.034 0.060 0 200 200 300 S5, TSMV-2
Nat. inf. 21 1.581 0.078 0 400 400 450 S5, TSMV-2
Nat. inf. 22 0.020 0.045 1 400 250 1,700 UGV, S5, TSMV-2
Nat. inf. 23 1.813 0.054 0 200 200 1,200 UGV, S5, TSMV-2
Nat. inf. 24 0.983 0.706 1 75 100 1,700 S5, TSMV-2
a

Abbreviations: 0-bleed, blood sample collected before initiation of the experimental work; final, blood sample collected during necropsy; postimm., blood sample collected following immunizations and prior to virus challenge; Nat. inf., naturally infected animal; ND, not determined. Blood smears were scored on a scale of 0 to 3, where a score of 0 is no IBs, 1 is small and/or rare IBs, 2 is medium-sized and/or occasional IBs, and 3 is large and/or numerous IBs.